† N.
D. Zelinsky Institute of Organic Chemistry, RAS, Leninsky Prospect, 47, 119991, Moscow, Russian Federation
‡ Institute
of Developmental Biology, RAS, Vavilov Street, 26, 119334, Moscow, Russian Federation
§ Chemical
Block Ltd., 3 Kyriacou
Matsi, 3723, Limassol, Cyprus
⊥ Life
Sciences Center, Moscow Institute of Physics
and Technology, Institutsky
Per., 9, Dolgoprudny, Moscow
Region 141700, Russian
Federation
∥ Institute
of Cell Biophysics, RAS, Institutskaya Street, 3, Pushchino, Moscow Region 142290, Russian Federation
J. Nat. Prod., 2016, 79 (5), pp 1429–1438
DOI: 10.1021/acs.jnatprod.6b00173
Publication Date (Web): April 21, 2016
Copyright © 2016 The American Chemical Society and American Society of Pharmacognosy
Abstract

A concise six-step protocol for the synthesis of isoflavone glaziovianin A (GVA) and its alkoxyphenyl derivatives 9
starting with readily available plant metabolites from dill and parsley
seeds was developed. The reaction sequence involved an efficient
conversion of the key intermediate epoxides 7 into the respective β-ketoaldehydes 8 followed by their Cu(I)-mediated cyclization into the target series 9.
The biological activity of GVA and its derivatives was evaluated using a
panel of seven human cancer cell lines and an in vivo sea urchin embryo
assay. Both screening platforms confirmed the antimitotic effect of the
parent GVA (9cg) and its alkoxy derivatives. Structure–activity relationship studies suggested that compounds 9cd and 9cf substituted with trimethoxy- and dillapiol-derived B-rings, respectively, were less active than the parent 9cg.
Of the evaluated human cancer cell lines, the A375 melanoma cell line
was the most sensitive to the tested molecules. Notably, the target
compounds were not cytotoxic against human peripheral blood mononuclear
cells up to 10 μM concentration. Phenotypic readouts from the sea urchin
assay unequivocally suggest a direct microtubule-destabilizing effect
of isoflavones 9cg, 9cd, and 9cf.